Quality of life in patients with liver metastases from colorectal cancer treated with first-line selective internal radiotherapy (SIRT): Results from the FOXFIRE prospective randomized studies

Quality of life in patients with liver metastases from colorectal cancer treated with first-line selective internal radiotherapy (SIRT): Results from the FOXFIRE prospective randomized studies

Quality of life (QoL) in patients with colorectal cancer and liver metastases treated with selective internal radiotherapy (SIRT) using Yttrium-90 resin microspheres combined with FOLFOX (standard chemotherapy) has not been compared to FOLFOX alone. We report QoL results from a prospectively pooled...

Повний опис

Бібліографічні деталі
Автори: Gray, A, Wolstenholme, J, Fusco, F, Chau, I, Dunham, L, Love, S, Roberts, A, Moschandreas, J, Virdee, P, Lewington, V, Wilson, G, Tait, P, Khan, N, Berry, D, Wotherspoon, A, Morgan, B, Wasan, H, Van Hazel, G, Gibbs, P, Sharma, R
Формат: Conference item
Опубліковано: Oxford University Press 2017
Опис
Резюме:Quality of life (QoL) in patients with colorectal cancer and liver metastases treated with selective internal radiotherapy (SIRT) using Yttrium-90 resin microspheres combined with FOLFOX (standard chemotherapy) has not been compared to FOLFOX alone. We report QoL results from a prospectively pooled analysis of 3 multicentre randomized trials: FOXFIRE, FOXFIRE-Global and SIRFLOX.

Схожі ресурси